[1]Lettersindrugdesignanddiscovery,2014,vol.11,p.349-354
34576-85-7
21815-91-8
13771-97-6
34576-87-9
84258-80-0
85992-25-2
62334-09-2 | 3,4-Methylenedioxyphenethyl isocyanate | AA003IGJ | MFCD03701575
79538-20-8 | 3,5-Difluorobenzyl alcohol | AA003IK1 | MFCD00046532
38660-35-4 | 3',6'-Bis(diethylamino)-2-phenylspiro[isoindoline-1,9'-xanthen]-3-one | AA003IN8 | MFCD00182788
54802-10-7 | 3-Aminobenzofuran-2-carboxamide | AA003IQX | MFCD00457147
17264-94-7 | 3-Aminobenzoic acid sodium salt | AA003IUH | MFCD00070552
870718-01-7 | 3-Bromo-2-isopropoxy-5-methylphenylboronic acid | AA003IXU | MFCD04974111
885952-18-1 | 3-Bromo-6-chloro-2-fluoropyridine | AA003J0O | MFCD06798230
186517-45-3 | 3-CHLORO-2-FLUORO-6-(TRIFLUOROMETHYL)BENZOYL CHLORIDE | AA003J40 | MFCD01631344
951885-19-1 | 3-Chloro-6-propylaminopyridazine | AA003J7D | MFCD09800940
61310-53-0 | 3-Ethoxyacrylonitrile (mixture of cis and trans) | AA003JAW | MFCD00010193
